Thus, whereas SHMT2 deletion will fully inhibit mitochondrial translation, SHMT2-targeted drugs might produce relevant anti-cancer effects without achieving the full depletion of mitochondrial 1C units [59]. The gene discussed is SHMT2; the disease is cancer.